SumitMadanMD

PubMed

• 1 citations
  Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavot...
  Leo I Gordon, Reem Karmali, Jason B Kaplan, Rakesh Popat, Howard A Burris 3rd, Silvia Ferrari, Sumit Madan, Manish R Patel, Giuseppe Gritti, Dima El-Sharkawi, F Ian Ch...> ;Oncotarget. 2023 Jan 26
• 9 citations
  Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment.
  Muhamed Baljevic, Cristina Gasparetto, Gary J Schiller, Sascha A Tuchman, Natalie S Callander, Suzanne Lentzsch, Jorge Monge, Rami Kotb, Nizar J Bahlis, Darrell White,...> ;Ejhaem. 2022 Nov 1
• Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B-Cell Non-Hodgkin's Lymphoma.
  Andres Forero-Torres, Jason Claud Chandler, Swaminathan P Iyer, Abraham S Kanate, Michelle Quinlan, Petra Hoever, Miguel Izquierdo, Jaclyn Davis, Sumit Madan> ;Clinical Pharmacology in Drug Development. 2022 Sep 1
• 17 citations
  Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients.
  Cristina Gasparetto, Gary J. Schiller, Sascha A. Tuchman, Natalie S. Callander, Muhamed Baljevic, Suzanne Lentzsch, Adriana C Rossi, Rami Kotb, Darrell White, Nizar J....> ;British Journal of Cancer. 2021 Nov 20
• 14 citations
  Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a study
  Kevin R. Kelly, Sikander Ailawadhi, David S. Siegel, Leonard T. Heffner, George Somlo, Sundar Jagannath, Todd M. Zimmerman, Nikhil C. Munshi, Sumit Madan, Asher Chanan...> ;The Lancet. Haematology. 2021 Nov 1
• 11 citations
  Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma
  Leo I. Gordon, Jason B. Kaplan, Rakesh Popat, Howard A. Burris, Silvia Ferrari, Sumit Madan, Manish R. Patel, Giuseppe Gritti, Dima El-Sharkawi, Ian Chau, John Radford...> ;Clinical Cancer Research. 2020 Jul 15
• 32 citations
  Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma...
  Anastasios Stathis, Ian W. Flinn, Sumit Madan, Kami J. Maddocks, Arnold S. Freedman, Steven D. Weitman, Emanuele Zucca, Mihaela C. Munteanu, M. Lia Palomba> ;Investigational New Drugs. 2018 Feb 17
• 70 citations
  High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement
  Sumit Madan, Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, David Dingli, S. Vincent Rajkumar, William J. Hogan, Nelson Leung, M...> ;Blood. 2012 Feb 2
• 46 citations
  Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma
  Sumit Madan, Martha Q. Lacy, Angela Dispenzieri, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, Kristen Detweiler-Short, David Dingli, Steven R. Zeldenrust, John...> ;Blood. 2011 Aug 18
• 57 citations
  Clinical Features and Treatment Response of Light Chain (AL) Amyloidosis Diagnosed in Patients With Previous Diagnosis of Multiple Myeloma
  Sumit Madan, Angela Dispenzieri, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, Steven R. Zeldenrust, S. Vincent Rajkumar, Morie A. Gertz, Shaji Kumar> ;Mayo Clinic Proceedings. 2010 Mar 1
• 18 citations
  Plasma cell labeling index in the evaluation of smoldering (asymptomatic) multiple myeloma.
  Sumit Madan, Robert A. Kyle, Philip R. Greipp> ;Mayo Clinic Proceedings. 2010 Mar 1
• 12 citations
  Review: extramedullary disease in multiple myeloma.
  Sumit Madan, Shaji Kumar> ;Clinical Advances in Hematology & Oncology. 2009 Dec 1
• 12 citations
  The incidental monoclonal protein: current approach to management of monoclonal gammopathy of undetermined significance (MGUS).
  Sumit Madan, Philip R. Greipp> ;Blood Reviews. 2009 Nov 1
• Join now to see all